rct
2008
High Quality
Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial
Unknown authors
Published in Nutrition
Key Findings
Twelve months of 40 g/day flaxseed raised plasma alpha-linolenic acid but did not significantly change fibrinogen, C-reactive protein or apolipoproteins versus wheat germ placebo.
Conclusions
Flaxseed does not lower fibrinogen in healthy menopausal women.
Limitations
Healthy population with normal baseline markers limits sensitivity.
Outcomes Measured
Flaxseed did not significantly alter fibrinogen, C-reactive protein or apolipoproteins compared with wheat germ placebo over 12 months.
Related Health Concerns
Study Details
Year:2008
Sample Size:199
Duration:52 weeks
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.